Cardiac/Pulmonary Conditions
At Cell Surgical Network, we strive to revolutionize cardiac and pulmonary care, redefining how we approach conditions like asthma, post-MI myocardial infarction, congestive heart failure, and chronic obstructive pulmonary disease (COPD).
Our goal is to harness the potential healing and restorative properties of autologous (your own) adult stem cells, specifically the regenerative cells found in stromal vascular fraction (SVF), within each patient’s own body. With these dependable procedures, we aim to improve our patients’ quality of life and overall health.
Discover how our advanced stem cell technologies can benefit your practice by getting in touch with our team to learn more. By offering a viable alternative to surgery, we can shape the future of cardiac and pulmonary healthcare. In the field of stem cell research, Cell Surgical Network takes pride in being a pioneer.
Asthma
Asthma, a chronic inflammatory disease of the airways, manifests as wheezing, coughing, chest tightness, shortness of breath, and bronchospasms. An asthma attack can be classified into two types based on symptom frequency: forced expiratory volume in one second (FEV1) and peak expiratory flow rate, and it can be exercise-induced or occupational.
To manage asthma-related airway inflammation, researchers worldwide harness adult stem cells’ anti-inflammatory and immune-modulatory properties. The Cell Surgical Network is leading this study, investigating the effects of a stem cell-rich, growth factor-rich therapy on chronic asthma.
Post-MI Myocardial Infarction
In myocardial infarction, a heart attack, blood flow is reduced, resulting in severe heart damage. It is often accompanied by further infarction and chronic angina, primarily due to coronary artery disease.
In regenerative medicine, the goal is to regenerate lost myocytes during cardiac ischemia. There is promising research in this area with adipose-derived mesenchymal stem cells, like those found in stromal vascular fraction (SVF).
Congestive Heart Failure (CHF) and Cardiomyopathy
Adult stem cells may provide a healing alternative for congestive heart failure (CHF) and cardiomyopathy. Cardiomyopathy is often associated with CHF, which causes numerous hospitalizations and deaths each year.
Clinical trials have demonstrated the safety and effectiveness of adult mesenchymal stem cells in managing cardiac disease, but research on the optimal source and delivery method remains ongoing.
Lung Disease
Adult stem cells are being studied for their anti-inflammatory and immune-modulatory properties in the field of lung disease, particularly chronic obstructive pulmonary disease (COPD).
Researchers worldwide are exploring the potential of adult stem cells to address the loss of elasticity and airway damage seen in COPD patients. As part of our research at Cell Surgical Network, we are investigating the effects of SVF, rich in mesenchymal stem cells and growth factors, on airway healing.
Join Cell Surgical’s Network Today
By joining the Cell Surgical Network, you gain insight into the future of cardiac and pulmonary care. We’re committed to expanding stem cell research to fight diseases such as asthma, heart failure, and chronic obstructive pulmonary disease. In addition to being anti-inflammatory and regenerative, adult stem cell research offers hope of improving respiratory health.
Become a member of our network and gain access to our trusted and proven research to help you improve your heart and pulmonary care. Contact our team today to learn more about our investigational protocols and how to incorporate our findings into your practice. Together, let us reshape cardiac and pulmonary healthcare in the future. You can make a difference through the Cell Surgical Network.